跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Solu-Medrol 1g powder for injection vial with diluent vial - TGA Drug Approval Details
Approvals
/
TGA
/
Solu-Medrol 1g powder for injection vial with diluent vial
Approved
STANDARD
Solu-Medrol 1g powder for injection vial with diluent vial
Pfizer Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
925a74a458e4fd07
Company
Pfizer Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
925a74a458e4fd07
Product Name
Solu-Medrol 1g powder for injection vial with diluent vial
Artg Id
12340
Artg Name
SOLU-MEDROL methylprednisolone (as sodium succinate) 1g powder for injection vial with diluent vial
Sponsor
Pfizer Australia Pty Ltd
Company Detail Path
/organization/pfizer-australia-pty-ltd
Artg Date
1991-08-02
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/c67ad6a433eba8cf52f0944a9b62240d.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/2b57451d28ea03ce1ca5c7f513d331fa.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
925a74a458e4fd07
Type
Standard
Back to TGA Approvals